25.08.2013 Views

össur annual report2009 - Euroland

össur annual report2009 - Euroland

össur annual report2009 - Euroland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Amortization classified by operational category, is shown in the following schedule:<br />

2009 2008<br />

Cost of goods sold 8 70<br />

Sales and marketing expenses 6,765 9,096<br />

Research and development expenses 3,441 4,185<br />

General and administrative expenses 354 1,404<br />

10,568 14,755<br />

Part of the intangible assets included above have finite useful lives, over which the assets are amortized.<br />

These intangible assets will be amortized on a straight line basis over their useful lives.<br />

The following useful lives are used in the calculation of amortisation.<br />

Customer and distribution relationships 4 - 5 years<br />

Patents 5 - 50 years<br />

Trademarks 3 - infinitive<br />

Other 3 - 10 years<br />

The Company main intangible assets are in relation to the acquisition of Royce Medical and<br />

Gibaud Group.The amortization in 2009 amounted to USD 10.5 million (2008: 14.8 million) and<br />

the expected amount for 2010 is USD 5.2 million. The Gibaud trademarks amounting to USD 16.1<br />

million are estimated to have infinitive life. The trademark has been well established within the<br />

French market since the foundation of the company in 1890.<br />

All amounts in thousands of USD 85 <strong>annual</strong> report 09<br />

Össur hf. consolidated financial stateMents 2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!